SAN DIEGO, June 29, 2020 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the…Original Article
Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain
